C5ORF22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.271600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.841800E-01
Normal-vs-Stage2
3.652200E-01
Normal-vs-Stage3
5.736300E-02
Normal-vs-Stage4
8.840400E-01
Stage1-vs-Stage2
8.192600E-01
Stage1-vs-Stage3
1.502850E-01
Stage1-vs-Stage4
5.675800E-01
Stage2-vs-Stage3
2.235600E-01
Stage2-vs-Stage4
4.049200E-01
Stage3-vs-Stage4
1.466640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.228600E-01
Normal-vs-AfricanAmerican
5.657400E-01
Normal-vs-Asian
7.583800E-01
Caucasian-vs-AfricanAmerican
4.890800E-01
Caucasian-vs-Asian
8.041500E-02
AfricanAmerican-vs-Asian
3.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.946760E-01
Normal-vs-Female
4.863600E-01
Male-vs-Female
2.843400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.988800E-01
Normal-vs-Age(41-60Yrs)
5.471000E-01
Normal-vs-Age(61-80Yrs)
2.653000E-01
Normal-vs-Age(81-100Yrs)
2.132800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.994000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.943400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.761400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.281800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.421800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.116840E-01
Normal-vs-Daily Drinker
1.603220E-01
Normal-vs-Weekly Drinker
7.969600E-01
Normal-vs-Occasional Drinker
5.025400E-01
Normal-vs-Social Drinker
3.266200E-01
Non Drinker-vs-Daily Drinker
9.861000E-01
Non Drinker-vs-Weekly Drinker
1.728840E-01
Non Drinker-vs-Occasional Drinker
9.766200E-02
Non Drinker-vs-Social Drinker
1.881390E-01
Daily Drinker-vs-Weekly Drinker
1.430960E-01
Daily Drinker-vs-Occasional Drinker
1.418590E-01
Daily Drinker-vs-Social Drinker
2.412200E-01
Weekly Drinker-vs-Occasional Drinker
7.217200E-01
Weekly Drinker-vs-Social Drinker
5.779000E-01
Occasional Drinker-vs-Social Drinker
7.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.295400E-01
Normal-vs-Grade 2
8.638400E-01
Normal-vs-Grade 3
8.830200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.482000E-01
Grade 1-vs-Grade 3
2.702000E-01
Grade 1-vs-Grade 4
8.295400E-01
Grade 2-vs-Grade 3
4.831200E-01
Grade 2-vs-Grade 4
8.638400E-01
Grade 3-vs-Grade 4
8.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.668000E-02
Normal-vs-NonDiabetic
3.483800E-01
Diabetic-vs-NonDiabetic
1.024610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.468400E-01
Normal-vs-NoPancreatitis
2.976000E-01
Pancreatitis-vs-NoPancreatitis
8.094400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.453400E-01
Normal-vs-N1
3.431200E-01
N0-vs-N1
7.655800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.120200E-01
Normal-vs-TP53-NonMutant
4.603600E-01
TP53-Mutant-vs-TP53-NonMutant
9.576000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
